Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Patricia K. Coyle, MD, FAAN, FANA

Professor of Neurology
Vice Chair for Academic Affairs
Director, MS Comprehensive Care Center
Stony Brook Renaissance School of Medicine
Stony Brook, New York

Disclosures

Patricia K. Coyle, MD, FAAN, FANA, has the following relevant financial relationships:
Consultant or advisor for: Accordant; Biogen; Bristol Myers Squibb Company; GlaxoSmithKline; Horizon Therapeutics; Lilly; Mylan Laboratories, Inc.; Novartis; Sanofi Genzyme; TG Therapeutics, Inc.
Contracted researcher for: Actelion Pharmaceuticals, Ltd; Alkermes, Inc.; Celgene Corporation; CorEvitas LLC; Genentech/Roche; MedDay Pharmaceuticals (former); Novartis; Sanofi Genzyme

Editor

Maya Khalaf, MSc

Medical Education Director, WebMD Global, LLC

Disclosures

Maya Khalaf, MSc, has no relevant financial relationships.

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

General Principles for the Use of Disease-Modifying Therapies in Multiple Sclerosis

Authors: Patricia K. Coyle, MD, FAAN, FANA
CME Released: 5/10/2023
Valid for credit through: 5/10/2024

Start Activity

Credits Available

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for neurologists (general neurologists and neurologists practicing in rural communities), primary care physicians, obstetricians/gynecologists, and other clinicians who treat patients with multiple sclerosis (MS).

The goal of this activity is for learners to be better able to consider clinical and prognostic factors in the selection of initial therapy for MS.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Goals of treatment in MS
- Prognostic factors associated with MS
- Clinical factors involved in selecting an initial therapy for the management of MS

Disclosures

Faculty

Patricia K. Coyle, MD, FAAN, FANA

Professor of Neurology
Vice Chair for Academic Affairs
Director, MS Comprehensive Care Center
Stony Brook Renaissance School of Medicine
Stony Brook, New York

Disclosures

Patricia K. Coyle, MD, FAAN, FANA, has the following relevant financial relationships:
Consultant or advisor for: Accordant; Biogen; Bristol Myers Squibb Company; GlaxoSmithKline; Horizon Therapeutics; Lilly; Mylan Laboratories, Inc.; Novartis; Sanofi Genzyme; TG Therapeutics, Inc.
Contracted researcher for: Actelion Pharmaceuticals, Ltd; Alkermes, Inc.; Celgene Corporation; CorEvitas LLC; Genentech/Roche; MedDay Pharmaceuticals (former); Novartis; Sanofi Genzyme

Editor

Maya Khalaf, MSc

Medical Education Director, WebMD Global, LLC

Disclosures

Maya Khalaf, MSc, has no relevant financial relationships.

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Neurology & Neurosurgery

CME

General Principles for the Use of Disease-Modifying Therapies in Multiple Sclerosis

Authors: Patricia K. Coyle, MD, FAAN, FANAFaculty and Disclosures

CME Released: 5/10/2023

Valid for credit through: 5/10/2024

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

Page 1 of 4

CME Information Download Slides

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Patricia K. Coyle, MD, FAAN, FANA

Editor

Maya Khalaf, MSc

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Peer Reviewer

CME

General Principles for the Use of Disease-Modifying Therapies in Multiple Sclerosis

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Patricia K. Coyle, MD, FAAN, FANA

Editor

Maya Khalaf, MSc

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

General Principles for the Use of Disease-Modifying Therapies in Multiple Sclerosis

Learning Feedback Questions